A5079971095- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- HIV-related health complications and treatments
- Dental Anxiety and Anesthesia Techniques
- Oral microbiology and periodontitis research
- Drug-Induced Adverse Reactions
Universidade Federal de Minas Gerais
2022-2023
Goal: In this study, we aimed to monitor the blood glucose, urea, and creatinine laboratory tests in treatment-naive individuals, initiating ART with an antiretroviral regimen containing EFV or DTG, searching for a contribution understanding of safety these drugs use real world, followed up 72 weeks. Methods: Cohort study follow-up people living HIV therapy. Results: An increase levels at 24 48 weeks glucose (p=0.017) was observed group using Dolutegravir. Those Efavirenz evidenced...
To describe trends of dentist-prescribed non-steroidal anti-inflammatory drugs (NSAIDs) and analgesics, from January 2011 to December 2021, as well examine the relationship between these characteristics public oral health services in Minas Gerais, Brazil. In this time-series analysis, all were classified according Anatomical Therapeutic Chemical classification system. Drugs categorized NSAIDs (M01A), other analgesics antipyretics (N02B) included for analysis. The outcome was number Defined...
Objetivo: verificar qual esquema de tratamento antirretroviral foi mais seguro para pessoa que vive com HIV, dolutegravir 50mg + lamivudina 300mg tenofovir ou efavirenz 600mg 300mg. Para isso, analisou-se os seguintes exames laboratoriais função hepática: bilirrubina total, direta e indireta, aspartato amino transferase, alanina gama glutamil transferase fosfatase alcalina. Metodologia: estudo coorte, o acompanhamento 234 pessoas vivem HIV iniciando terapia na cidade Belo Horizonte, Minas...